Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs.

Muguruza C, Meana JJ, Callado LF.

Front Pharmacol. 2016 May 20;7:130. doi: 10.3389/fphar.2016.00130. eCollection 2016. Review.

2.

Metabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A Review.

Matrisciano F, Panaccione I, Grayson DR, Nicoletti F, Guidotti A.

Curr Neuropharmacol. 2016;14(1):41-7.

3.

Therapeutic Targets for Neurodevelopmental Disorders Emerging from Animal Models with Perinatal Immune Activation.

Ibi D, Yamada K.

Int J Mol Sci. 2015 Nov 27;16(12):28218-29. doi: 10.3390/ijms161226092. Review.

4.

Converging models of schizophrenia--Network alterations of prefrontal cortex underlying cognitive impairments.

Sakurai T, Gamo NJ, Hikida T, Kim SH, Murai T, Tomoda T, Sawa A.

Prog Neurobiol. 2015 Nov;134:178-201. doi: 10.1016/j.pneurobio.2015.09.010. Epub 2015 Sep 25. Review.

PMID:
26408506
5.

Decreased Na(+) influx lowers hippocampal neuronal excitability in a mouse model of neonatal influenza infection.

Park H, Yu JE, Kim S, Nahm SS, Chung C.

Sci Rep. 2015 Aug 27;5:13440. doi: 10.1038/srep13440.

6.

Epigenetic Mechanisms of Serotonin Signaling.

Holloway T, González-Maeso J.

ACS Chem Neurosci. 2015 Jul 15;6(7):1099-109. doi: 10.1021/acschemneuro.5b00033. Epub 2015 Mar 10. Review.

7.

Prenatal immune challenge in rats: effects of polyinosinic-polycytidylic acid on spatial learning, prepulse inhibition, conditioned fear, and responses to MK-801 and amphetamine.

Vorhees CV, Graham DL, Braun AA, Schaefer TL, Skelton MR, Richtand NM, Williams MT.

Neurotoxicol Teratol. 2015 Jan-Feb;47:54-65. doi: 10.1016/j.ntt.2014.10.007. Epub 2014 Nov 8.

8.
9.

Manganese-enhanced magnetic resonance imaging reveals increased DOI-induced brain activity in a mouse model of schizophrenia.

Malkova NV, Gallagher JJ, Yu CZ, Jacobs RE, Patterson PH.

Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):E2492-500. doi: 10.1073/pnas.1323287111. Epub 2014 Jun 2. Erratum in: Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14307.

10.

Increased behavioral and neuronal responses to a hallucinogenic drug in PACAP heterozygous mutant mice.

Hazama K, Hayata-Takano A, Uetsuki K, Kasai A, Encho N, Shintani N, Nagayasu K, Hashimoto R, Reglodi D, Miyakawa T, Nakazawa T, Baba A, Hashimoto H.

PLoS One. 2014 Feb 20;9(2):e89153. doi: 10.1371/journal.pone.0089153. eCollection 2014.

11.

Emerging influenza and psychosis: an important story in psychological medicine.

Wiwanitkit V.

Indian J Psychol Med. 2013 Apr;35(2):222-3. doi: 10.4103/0253-7176.116269. No abstract available.

12.

Serotonergic hallucinogens as translational models relevant to schizophrenia.

Halberstadt AL, Geyer MA.

Int J Neuropsychopharmacol. 2013 Nov;16(10):2165-80. doi: 10.1017/S1461145713000722. Epub 2013 Aug 13. Review.

13.

Immune system disturbances in schizophrenia.

Horváth S, Mirnics K.

Biol Psychiatry. 2014 Feb 15;75(4):316-23. doi: 10.1016/j.biopsych.2013.06.010. Epub 2013 Jul 25. Review.

14.

Preclinical models of antipsychotic drug action.

Moreno JL, González-Maeso J.

Int J Neuropsychopharmacol. 2013 Nov;16(10):2131-44. doi: 10.1017/S1461145713000606. Epub 2013 Jun 10. Review.

15.

Early life exposure to the 1918 influenza pandemic and old-age mortality by cause of death.

Myrskylä M, Mehta NK, Chang VW.

Am J Public Health. 2013 Jul;103(7):e83-90. doi: 10.2105/AJPH.2012.301060. Epub 2013 May 16.

16.

Repressive epigenetic changes at the mGlu2 promoter in frontal cortex of 5-HT2A knockout mice.

Kurita M, Moreno JL, Holloway T, Kozlenkov A, Mocci G, García-Bea A, Hanks JB, Neve R, Nestler EJ, Russo SJ, González-Maeso J.

Mol Pharmacol. 2013 Jun;83(6):1166-75. doi: 10.1124/mol.112.084582. Epub 2013 Mar 18.

17.

Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement.

Halberstadt AL, Geyer MA.

Psychopharmacology (Berl). 2013 Jun;227(4):727-39. doi: 10.1007/s00213-013-3006-z. Epub 2013 Feb 14.

18.

Prenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune system.

Holloway T, Moreno JL, Umali A, Rayannavar V, Hodes GE, Russo SJ, González-Maeso J.

J Neurosci. 2013 Jan 16;33(3):1088-98. doi: 10.1523/JNEUROSCI.2331-12.2013.

19.

HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity.

Kurita M, Holloway T, García-Bea A, Kozlenkov A, Friedman AK, Moreno JL, Heshmati M, Golden SA, Kennedy PJ, Takahashi N, Dietz DM, Mocci G, Gabilondo AM, Hanks J, Umali A, Callado LF, Gallitano AL, Neve RL, Shen L, Buxbaum JD, Han MH, Nestler EJ, Meana JJ, Russo SJ, González-Maeso J.

Nat Neurosci. 2012 Sep;15(9):1245-54. doi: 10.1038/nn.3181. Epub 2012 Aug 5.

20.

Effects of maternal immune activation on gene expression patterns in the fetal brain.

Garbett KA, Hsiao EY, Kálmán S, Patterson PH, Mirnics K.

Transl Psychiatry. 2012 Apr 3;2:e98. doi: 10.1038/tp.2012.24.

Items per page

Supplemental Content

Write to the Help Desk